Skip to content

Measuring Comfort During Palliative Sedation

Towards a Better Understanding of What Palliative Sedated Patients Experience: Linking Numbers to Experiences

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03273244
Acronym
COMPAS
Enrollment
12
Registered
2017-09-06
Start date
2017-05-12
Completion date
2019-09-30
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Sedation

Brief summary

Background. In case of untreatable suffering at the end of life, palliative sedation may be chosen to assure comfort by reducing the patient's level of consciousness. An important question here is whether such sedated patients are certainly completely free of pain. Because these patients cannot communicate anymore, caregivers have to rely on observation to assess the patient's comfort. Recently however, more sophisticated techniques from the neurosciences (fMRI, EEG) have shown that sometimes consciousness and pain is undetectable with these traditional behavioral methods. Therefore there is an urgent need for a more reliable way of assessment by combining existing observational scales, subjective assessments of caregivers and family and neuroimaging techniques. Aim. The aim of this study is to better understand how unconscious palliative sedated patients experience the last days of their life and to find out if they are really free of pain. Methods In this study the investigators will observe 40 patients starting with initiation of palliative sedation until death. Assessment of comfort based on behavioural observations will be related with the results from a NeuroSense monitor, an EEG-based brain monitor used for evaluation of the adequacy of anesthesia and sedation in the operating room and an ECG-based Analgesia Nociception Index (ANI) monitor, which informs about the comfort or discomfort condition of the organism, based on the parasympathetic tone (including calculation of ANI). Additionally, the researchers will investigate whether changes of these measures can be linked to changes in the patients' experience as observed by caregivers and relatives, especially in the last moments of life. An innovative and challenging aspect of this study is its qualitative approach, implying all the different types of data will be used to link objective and subjective data to achieve a holistic understanding of the study topics. The following data will be collected: * assessment of pain/comfort by the patients themselves before loss of consciousness due to deep continuous sedation (if possible) by scoring a Visual Analogue Scale (VAS) * brain function monitoring (NeuroSense monitor) * monitoring of parasympathetic tone (ANI monitor) * assessment by caregivers on 3 VAS scales (different scales or 3 different caregivers?) * relatives' perception of the quality of the dying process on 3 VAS scales (idem) * assessment by 2 trained investigators using observational scales * observation: video and audio registration

Interventions

DEVICENeuroSense monitoring and ANI monitoring

From the start of palliative sedation, monitoring of EEG with NeuroSense device (WAVcns: Wavelet Anesthetic Value of the Central Nervous System) and ANI-monitoring (Analgesia Nociception Index) will be initiated.

Sponsors

Vrije Universiteit Brussel
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients may be included if they are considered by their treating physician as: 1. in their last week of life 2. in conditions that might, when not treated, cause high levels of distress 3. sedated 4. unable to communicate

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Level of awarenessFrom date of enrollment until the date of death, on average less than 1 week.Level of awareness as measured by a NeuroSense monitor and expressed as the WAVcns index (Wavelet-based Anesthetic Value for Central Nervous System). The WAVcns is based on cortical EEG.
Level of pain and discomfortFrom date of enrollment until the date of death, on average less than 1 week.Level of pain and discomfort as measured by an ANI-monitor and expressed by the analgesia nociception index (ANI). The ANI is based on HRV (heart rate variability).

Secondary

MeasureTime frameDescription
PainFrom date of enrollment until the date of death (on average less than 1 week), during routine care, at least twice a day.Visual analog score assessment by nurse
AwarenessFrom date of enrollment until the date of death (on average less than 1 week), during routine care, at least twice a day.Visual analog score assessment by nurse
CommunicationFrom date of enrollment until the date of death (on average less than 1 week), during routine care, at least twice a day.Visual analog score assessment by nurse

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026